Leishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites
of the genus Leishmania for which there is a paucity of effective viable non-toxic drugs …

There is no effective cure for Chagas disease, which is caused by infection with the
arthropod-borne parasite, Trypanosoma cruzi. In the search for new drugs to treat Chagas …

Leishmania donovani is the causing agent of visceral leishmaniasis, a common infection
that affects millions of people from the most underdeveloped countries. Miltefosine is the …

Parasitic diseases are still a huge problem for mankind. They are becoming the main cause
of chronic diseases in the world. Migration of the population, pollution of the natural …

Parasitic diseases such as Kala azar (visceral leishmaniasis), Chagas disease (American
trypanosomiasis) and African sleeping sickness (human African trypanosomiasis) are …

Leishmaniasis is a complex of diseases with numerous clinical manifestations for instance
harshness from skin lesions to severe disfigurement and chronic systemic infection in the …

There are many challenges facing the successful control and eradication of cutaneous and
visceral leishmaniasis. Leishmaniasis is still endemic in many poverty stricken and war torn …

Despite the existence of chemotherapy, there is no effective cure for leishmaniasis. In the
light of recommended therapeutic regimen is attributed for toxicity and development of …

Although miltefosine and paromomycin were registered as clinical agents against visceral
leishmaniasis in the last decade, the antileishmanial drug arsenal still requires …

Amiodarone (AMIO), the most frequently antiarrhythmic drug used for the symptomatic
treatment of chronic Chagas′ disease patients with cardiac compromise, has recently been …